Compugen (CGEN): Volume dodolan mangsa ngarep perusahaan
The strategy of Compugen Ltd. (CGEN) focuses on the efficient management of its biotech platform with transparent control over clinical trials. The company's projected revenue illustrates the stages of achieving this goal, where 0.08 determines this specific parameter level. However, unique target-discovery software requires high licensing payments, while reliance on partner payments and R&D losses create significant financial barriers.
CGEN (Compugen Limited): rincian analitis lan laporan miturut indikator
- nilai saham lan prakiraan konsensus rega:
- data kapitalisasi bursa:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Rasio Total Utang marang Ekuitas Compugen Ltd.|CGEN - Tanggungan utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Compugen Ltd.|CGEN - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Compugen Ltd|CGEN - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Compugen|Likuiditas cepet cgen.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
CGEN - Bathi pungkasan|Proyeksi bathi mangsa ngarep Compugen Ltd.|CGEN - Pangali P/E|Rega marang bathi mangsa ngarep Compugen Ltd.|CGEN - Rasio kapitalisasi marang bathi lan wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Compugen Ltd|CGEN - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) Compugen|CGEN - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan cgen.com|CGEN - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Compugen Ltd.
- indikator pendapatan dodolan lan penghasilan bisnis:
Ringkesan analisis perusahaan:Compugen
This indicator aggregates long-term revenue forecasts, reflecting the market's reassessment of the issuer's fundamental potential amid structural changes in the sector. For Compugen Ltd. (CGEN), future sales proceeds depend directly on the commercialization of unique IT platforms for cancer therapy target discovery and the scale of licensing payments from global pharmaceutical behemoths.
Pesaing langsung
Prakiraan pendapatan perusahaan ImmunityBio, Inc. (IBRX)|Volume dodolan mangsa ngarep perusahaan immunocore.com IMCR|Janux Therapeutics, Inc. - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan Arcus Biosciences Inc RCUS|ZYME - Prakiraan pendapatan perusahaan|TNGX (Tango Therapeutics Corp) - Prakiraan pendapatan perusahaan|Iovance Biotherapeutics (IOVA) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan immatics.com (IMTX)|Volume dodolan mangsa ngarep perusahaan XNCR|CMPX - Prakiraan dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan REPL (Replimune Corp)|Prakiraan volume pendapatan perusahaan LYEL|Prakiraan volume dodolan IPHA (Innate Pharma S.A.)|Pendapatan mangsa ngarep perusahaan PYXS|IO Biotech - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan Sutro Biopharma Inc.|MiNK (INKT) - Prakiraan pendapatan perusahaan|Werewolf Therapeutics, Inc. - Pendapatan mangsa ngarep perusahaan|IMMX (Immix Biopharma Inc.) - Prakiraan volume dodolan|Prakiraan volume dodolan alxoncology.com|Prakiraan pendapatan perusahaan Cue Biopharma (CUE)|PDSB: Pendapatan sing dikarepake perusahaan|Sonnet BioTherapeutics Holdings - Volume dodolan mangsa ngarep perusahaan|MAIA Bio (MAIA) - Volume dodolan sing dikarepake perusahaan|Liminatus Pharma - Prakiraan volume dodolan|LAVA Therapeutics N.V. (LVTX) - Volume dodolan mangsa ngarep perusahaan|NextCure (NXTC) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Leap Therapeutics (LPTX)|Prakiraan pendapatan perusahaan Intensity Therapeutics Inc|Volume dodolan mangsa ngarep perusahaan Sensei Bio (SNSE)|Prakiraan pendapatan perusahaan Theriva Biologics, Inc. (TOVX)|GRTS: Pendapatan sing dikarepake perusahaan|Kineta - Volume dodolan mangsa ngarep perusahaan|Prakiraan volume dodolan NexImmune Inc NEXI|Turnstone Biologics Corporation - Prakiraan volume dodolan|Prakiraan dodolan perusahaan Vaccinex Inc (VCNX)|HARP: Prakiraan volume dodolan
